A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection

Haruki Funao, Shigenori Nagai, Aya Sasaki, Tomoyuki Hoshikawa, Takashi Tsuji, Yasunori Okada, Shigeo Koyasu, Yoshiaki Toyama, Masaya Nakamura, Mamoru Aizawa, Morio Matsumoto, Ken Ishii

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Various silver-coated implants have been developed to prevent implant-associated infections, and have shown dramatic effects in vitro. However, the in vivo results have been inconsistent. Recent in vitro studies showed that silver exerts antibacterial activity by mediating the generation of reactive oxygen species in the presence of oxygen. To maintain its antibacterial activity in vivo, the silver should remain in an ionic state and be stably bound to the implant surface. Here, we developed a novel bacteria-resistant hydroxyapatite film in which ionic silver is immobilized via inositol hexaphosphate chelation using a low-heat immersion process. This bacteria-resistant coating demonstrated significant antibacterial activity both in vitro and in vivo. In a murine bioluminescent osteomyelitis model, no bacteria were detectable 21 days after inoculation with S. aureus and placement of this implant. Serum interleukin-6 was elevated in the acute phase in this model, but it was significantly lower in the ionic-silver group than the control group on day 2. Serum C-reactive protein remained significantly higher in the control group than the ionic-silver group on day 14. Because this coating is produced by a low-heat immersion process, it can be applied to complex structures of various materials, to provide significant protection against implant-associated infections.

Original languageEnglish
Article number23238
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - 17-03-2016
Externally publishedYes

Fingerprint

Phytic Acid
Durapatite
Silver
Infection
Immersion
Bacteria
Hot Temperature
Control Groups
Osteomyelitis
C-Reactive Protein
Blood Proteins
Interleukin-6
Reactive Oxygen Species
Oxygen
Serum
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • General

Cite this

Funao, Haruki ; Nagai, Shigenori ; Sasaki, Aya ; Hoshikawa, Tomoyuki ; Tsuji, Takashi ; Okada, Yasunori ; Koyasu, Shigeo ; Toyama, Yoshiaki ; Nakamura, Masaya ; Aizawa, Mamoru ; Matsumoto, Morio ; Ishii, Ken. / A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection. In: Scientific Reports. 2016 ; Vol. 6.
@article{2f20e147aa0d468da3ffc5e5d102c710,
title = "A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection",
abstract = "Various silver-coated implants have been developed to prevent implant-associated infections, and have shown dramatic effects in vitro. However, the in vivo results have been inconsistent. Recent in vitro studies showed that silver exerts antibacterial activity by mediating the generation of reactive oxygen species in the presence of oxygen. To maintain its antibacterial activity in vivo, the silver should remain in an ionic state and be stably bound to the implant surface. Here, we developed a novel bacteria-resistant hydroxyapatite film in which ionic silver is immobilized via inositol hexaphosphate chelation using a low-heat immersion process. This bacteria-resistant coating demonstrated significant antibacterial activity both in vitro and in vivo. In a murine bioluminescent osteomyelitis model, no bacteria were detectable 21 days after inoculation with S. aureus and placement of this implant. Serum interleukin-6 was elevated in the acute phase in this model, but it was significantly lower in the ionic-silver group than the control group on day 2. Serum C-reactive protein remained significantly higher in the control group than the ionic-silver group on day 14. Because this coating is produced by a low-heat immersion process, it can be applied to complex structures of various materials, to provide significant protection against implant-associated infections.",
author = "Haruki Funao and Shigenori Nagai and Aya Sasaki and Tomoyuki Hoshikawa and Takashi Tsuji and Yasunori Okada and Shigeo Koyasu and Yoshiaki Toyama and Masaya Nakamura and Mamoru Aizawa and Morio Matsumoto and Ken Ishii",
year = "2016",
month = "3",
day = "17",
doi = "10.1038/srep23238",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

Funao, H, Nagai, S, Sasaki, A, Hoshikawa, T, Tsuji, T, Okada, Y, Koyasu, S, Toyama, Y, Nakamura, M, Aizawa, M, Matsumoto, M & Ishii, K 2016, 'A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection', Scientific Reports, vol. 6, 23238. https://doi.org/10.1038/srep23238

A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection. / Funao, Haruki; Nagai, Shigenori; Sasaki, Aya; Hoshikawa, Tomoyuki; Tsuji, Takashi; Okada, Yasunori; Koyasu, Shigeo; Toyama, Yoshiaki; Nakamura, Masaya; Aizawa, Mamoru; Matsumoto, Morio; Ishii, Ken.

In: Scientific Reports, Vol. 6, 23238, 17.03.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection

AU - Funao, Haruki

AU - Nagai, Shigenori

AU - Sasaki, Aya

AU - Hoshikawa, Tomoyuki

AU - Tsuji, Takashi

AU - Okada, Yasunori

AU - Koyasu, Shigeo

AU - Toyama, Yoshiaki

AU - Nakamura, Masaya

AU - Aizawa, Mamoru

AU - Matsumoto, Morio

AU - Ishii, Ken

PY - 2016/3/17

Y1 - 2016/3/17

N2 - Various silver-coated implants have been developed to prevent implant-associated infections, and have shown dramatic effects in vitro. However, the in vivo results have been inconsistent. Recent in vitro studies showed that silver exerts antibacterial activity by mediating the generation of reactive oxygen species in the presence of oxygen. To maintain its antibacterial activity in vivo, the silver should remain in an ionic state and be stably bound to the implant surface. Here, we developed a novel bacteria-resistant hydroxyapatite film in which ionic silver is immobilized via inositol hexaphosphate chelation using a low-heat immersion process. This bacteria-resistant coating demonstrated significant antibacterial activity both in vitro and in vivo. In a murine bioluminescent osteomyelitis model, no bacteria were detectable 21 days after inoculation with S. aureus and placement of this implant. Serum interleukin-6 was elevated in the acute phase in this model, but it was significantly lower in the ionic-silver group than the control group on day 2. Serum C-reactive protein remained significantly higher in the control group than the ionic-silver group on day 14. Because this coating is produced by a low-heat immersion process, it can be applied to complex structures of various materials, to provide significant protection against implant-associated infections.

AB - Various silver-coated implants have been developed to prevent implant-associated infections, and have shown dramatic effects in vitro. However, the in vivo results have been inconsistent. Recent in vitro studies showed that silver exerts antibacterial activity by mediating the generation of reactive oxygen species in the presence of oxygen. To maintain its antibacterial activity in vivo, the silver should remain in an ionic state and be stably bound to the implant surface. Here, we developed a novel bacteria-resistant hydroxyapatite film in which ionic silver is immobilized via inositol hexaphosphate chelation using a low-heat immersion process. This bacteria-resistant coating demonstrated significant antibacterial activity both in vitro and in vivo. In a murine bioluminescent osteomyelitis model, no bacteria were detectable 21 days after inoculation with S. aureus and placement of this implant. Serum interleukin-6 was elevated in the acute phase in this model, but it was significantly lower in the ionic-silver group than the control group on day 2. Serum C-reactive protein remained significantly higher in the control group than the ionic-silver group on day 14. Because this coating is produced by a low-heat immersion process, it can be applied to complex structures of various materials, to provide significant protection against implant-associated infections.

UR - http://www.scopus.com/inward/record.url?scp=84961778306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961778306&partnerID=8YFLogxK

U2 - 10.1038/srep23238

DO - 10.1038/srep23238

M3 - Article

C2 - 26984477

AN - SCOPUS:84961778306

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 23238

ER -